Uses and effectiveness of pamidronate disodium for treatment of dogs and cats with hypercalcemia

Journal of Veterinary Internal Medicine

Volumn 19, Issue 1, 2005, Pages 29-33

  Hostutler, Roger A ^a,e   Chew, Dennis J ^a   Jaeger, Jordan Q ^b   Klein, Susan ^c   Henderson, Deborah ^d   DiBartola, Stephen P ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b Carolina Veterinary Specialists   (United States)

^c Angell Memorial Animal Hospital   (United States)

^d Toronto Veterinary Emergency and Referral Hospital   (Canada)

^e Veterinary Specialty Hospital of the Carolinas   (United States)

Author keywords

Bisphosphonates; Calcipotriene; Malignancy; Toxicity

Indexed keywords

CALCIPOTRIOL; CALCIUM; PAMIDRONIC ACID;

ARTICLE; CALCIUM BLOOD LEVEL; CAT; CAT DISEASE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DOG; DOG DISEASE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; EXTRACELLULAR FLUID; HYPERCALCEMIA; NEOPLASM; NOCARDIOSIS; NONHUMAN; TOXICITY;

ANIMALS; CALCIUM; CATS; DIPHOSPHONATES; DOG DISEASES; DOGS; FEMALE; HYPERCALCEMIA; MALE; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS; FELIS CATUS;

EID: 13544251619     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2005)19<29:UAEOPD>2.0.CO;2     Document Type: Article

References (23)

1. Berger B, Feldman EC. Primary Hyperparathyroidism in Dogs: 21 cases (1976-1986). J Am Vet Med Assoc 1987;191:350-356.
2. Rosol TJ, Nagode LA, Chew DJ, et al. Disorders of calcium. In: DiBartola SP, ed. Fluid Therapy in Small Animal Practice, 2nd ed. Philadelphia, PA: WB Saunders; 2000:108-162.
3. Peterson ME, Feinman JM. Hypercalcemia associate with hypoadrenocorticism in 16 dogs. J Am Vet Med Assoc 1982;181:802-804.
4. Dorman DC. Toxicology of selected pesticides, drugs, and chemicals. Anticoagulant, cholecalciferol, and bromethalin-based rodenticides. Vet Clin North Am Small Anim Pract. 1996;26:1417-1445.
5. Pesillo SA, Khan SA, Rozanski EA, et al. Calcipotriene toxicosis in a dog successfully treated with pamidronate disodium. J Vet Emerg Crit Care 2002;12:177-181.
6. Vasilopulos RJ, Mackin A. Humoral hypercalcemia of malignancy: Pathophysiology and clinical signs. Compend Contin Educ Pract Vet 2003;25:122-128.
7. Mealey KL, Willard MD, Nagode LA, et al. Hypercalcemia associated with granulomatous disease in a cat. J Am Vet Med Assoc 1999;215:959-962.
8. Arceneauz KA, Taboada J, Hosgood G. Blastomycosis in dogs: 115 cases. J Am Vet Med Assoc 1998;213:658-664.
9. Midkiff AM, Chew DJ, Randolf JF, et al. Idiopathic hypercalcemia in cats. J Vet Intern Med 2000;14:619-626.
10. Schenk PA, Chew DJ. Determination of calcium fractionation in dogs with chronic renal failure. Am J Vet Res 2003;64:1181-1184.
11. Theriault RL, Hortobagyi GN. The evolving role of bisphosphonates. Semin Oncol 2001;28:284-290.
12. Coleman RE. Optimising treatment of bone meatstases by Aredia™ and Zometa™. Breast Cancer 2000;7:361-369.
13. Kanis JA, McCloskey EV. Bisphosphanates in multiple myeloma. Cancer 2000;88(12 Suppl):3022-3032.
14. Elomaa I. Use of bisphosphonates in skeletal metastasis. Acta Oncol 2000;39:445-454.
15. Coleman RE. Should bisphosphanates be the treatment of choice for metastatic bone disease? Semin Oncol 2001;28(4 Suppl 11): 35-41.
16. Rumbeiha WK, Kruger JM, Fitzgerald SF, et al. Use of pamidronate to reverse vitamin D3-induced toxicosis in dogs. Am J Vet Res 1999;60:1092-1097.
17. Rumbeiha WK, Fitzgerald SF, Kruger JM, et al. Use of pamidronate disodium to reduce cholecalciferol-induced toxicosis in dogs. Am J Vet Res 2000;61:9-13.
18. Kadar E, Rush JE, Wetmore L, et al. Electrolyte disturbances and cardiac arrhythmias in a dog following pamidronate, calcitonin, and furosemide administration for hypercalcemia of malignancy. J Am Anim Hosp Assoc 2004;40:75-81.
19. Tomlin JL, Sturgeon C, Pead MJ, et al. Use of the bisphosphanate drug Alendronate for palliative management of osteosarcoma in two dogs. Vet Rec 2000; July: 129-132.
20. Davenport A, Goel S, Mackenzie JC. Treatment of hypercalcaemia with pamidronate in patients with end stage renal failure. Scand J Urol Nephrol 1993;27:447-451.
21. Machado CE, Flombaum CD. Safety of pamidronate in patients with renal failure and hypercalcemia. Clin Nephrol 1996;45:175-179.
22. Sellers E, Sharma A, Rodd C. The use of pamidronate in three children with renal disease. Pediatr Nephrol 1998;12:778-781.
23. Morrow C. Cholecalciferol poisoning. Vet Med 2001;96:905-911.